Lupin gets approval for Mycophenolic Acid Delayed-Release Tablets USP, 180 mg and 360 mg. Mycophenolic Acid Delayed-Release Tablets USP had annual sales of approximately $174M in the U.S. The stock was up 0.5%.
Feedback
LUPIN 
Reputation: 29,954 • Dec 19, 2019 10:13 PM
Vote
Comment
Share